Genetic chaos and antichaos in human cancers

Medical Hypotheses

Volumn 60, Issue 2, 2003, Pages 258-262

  Calin, George Adrian ^a,d   Vasilescu, Catalin ^b   Negrini, Massimo ^a,c   Barbanti Brodano, Giuseppe ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c UNIVERSITY OF FERRARA   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER; CARCINOGENESIS; CHAOTIC DYNAMICS; GENE ACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HYPOTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

HUMANS; NEOPLASMS; NONLINEAR DYNAMICS; SIGNAL TRANSDUCTION;

EID: 0037320986     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00383-3     Document Type: Article

References (39)

1. Goldberg A. L., Rigney D. R., West B. J. Chaos and fractals in human physiology. Sci Am 1990; 262: 36-41.
2. Denton T. A., Diamond G. A., Helfant R. H., Khan S., Karagneuzian H. Fascinating rhythm: a primer on chaos theory and its application to cardiology. Am Heart J 1990; 120: 1419-1440.
3. Cross S. S., Cotton D. W. K. Chaos and antichaos in pathology. Hum Pathol 1994; 25: 630-637.
4. Bishop J. M. Molecular themes in oncogenesis. Cell 1991; 64: 235-248.
5. Weinberg R. A. Tumor suppressor genes. Science 1991; 254: 1138-1146.
6. Coffey D. S. Self-organization-complexity and chaos: the new biology for medicine. Nat Med 1998; 4: 882-883.
7. Rew D. A. Heterogeneity, biodiversity and bioperversity in solid neoplasms. Eur J Surg Oncol 1996; 22: 469-473.
8. Posades E. H., Criley S. R., Coffey D. Chaotic oscillations in cultured cells: rat prostate cancer. Cancer Res 1996; 56: 3682-3688.
9. Sedivy R., Mader R. M. Fractols, chaos and cancer: do they coincide?. Cancer Invest 1997; 15: 601-607.
10. Hagmann M. Doing immunology on a chip. Science 2000; 290: 82-83.
11. Calin G., Ivan M., Stefanescu D. T. The difference between p53 mutation frequency in haematological and nonhaematologicol malignancies: possible explanations. Med Hypotheses 1999; 53: 326-328.
12. Shtivelman E., Lifshitz B., Gale R. P., Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 1985; 315: 550-554.
13. Look A. T. Genes altered by chromosomal translocations in leukemias and lymphomas. In: B. Vogelstein, K. W. Kinzler (eds). The Genetic Basis of Human Cancer. New York: McGraw-Hill, 1998: 109-141.
14. Daley G. Q., Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia specific P210bcr/abl protein. Proc Natl Acad Sci USA 1988; 85: 9312-9318.
15. Deininger M. W. N., Goldman J. M., Melo J. V. The molecular biology of chronic myeloid leukemia. Blood 2000; 96: 3343-3356.
16. Tsujimoto Y., Gorham J., Cossman J., Jaffe E., Croce C. M. The t(14; 18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390-1393.
17. Gu Y., Nakamura T., Alder H. et al. The t(4; 11) chromosome translocation of human acute leukemias fuses the ALL-1 gene related to Drosophila tritorax to the AF-4 gene. Cell 1992; 71: 701-710.
18. Poon C. S., Merrill C. K. Decrease of cardiac chaos in congestive heart failure. Nature 1997; 389: 492-495.
19. Couch F. J., Weber B. L. Breast cancer. In: B. Vogelstein, K. W. Kinzler (eds). The Genetic Basis of Human Cancer. New York: McGraw-Hill, 1998: 537-563.
20. Calin G. A., di Iasio M. G., Caprini E. et al. Low frequency of alterations of the PPP2R1A and PPP2R1B isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 2000; 19: 1191-1195.
21. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-768.
22. Meltzer P. S., Trent J. M. Chromosome rearrangements in human solid tumors. In: B. Vogelstein, K W. Kinzler (eds). The genetic basis of human cancer. New York: McGraw-Hill, 1998: 143-160.
23. Perou C. M., Sorlie T., Eisen M. B. et al. Molecular portraits of human breast tumors. Nature 2000; 406: 747-757.
24. Weng G., Bhalla U. S., Iyengar R. Complexity in biological signaling systems. Science 1999; 284: 92-96.
25. Johnston R. N., Pai S. B., Pai R. B. The origin of the cancer cell: oncogeny reverses phylogeny. Biochem Cell Biol 1992; 70: 831-834.
26. Calin G., Stefanescu D. Can the loss of negative regulation theory be compatible with the development of hematological malignancies?. Oncol Rep 1995; 2: 875-878.
27. Philips R. L., Ernst R. E., Brunk B. et al. The genetic program of hematopoietic stem cells. Science 2000; 288: 1635-1640.
28. Iyer V. R., Eisen M. B., Ross D. T. et al. The transcriptional program in response of human fibroblasts to serum. Science 2000; 283: 83-87.
29. Mariadason J. M., Corner G. A., Augenlicht L. H. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 2001; 60: 4561-4572.
30. Greider C. W. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998; 95: 90-92.
31. Wright W. E., Shay J. W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 2000; 6: 849-851.
32. Mattfeldt T. Nonlinear deterministic analysis of tissue texture: a stereological study on mastopathic and mammary cancer tissue using chaos theory. J Microsc 1997; 185: 47-66.
33. Look A. T. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059-1064.
34. Hunter T. Oncogenic networks. Cell 1997; 88: 333-346.
35. Sidransky D., Tokino T., Hamilton S. R. et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256: 102-105.
36. Dubois R. N., Smalley W. E. Cyclooxygenases, NSAIDs and colorectal cancer. J Gastroenterol 1996; 6: 898-906.
37. Hauk E., Lubert R., Limburg P. Chemoprevention in hereditary colorectal cancer syndromes. Cancer 1999; 86: 2551-2563.
38. Torrance C. J., Jackson P. E., Montgomery E. et al. Combinatorial chemoprevention of intestinal neoplasia. Nat Med 2000; 6: 1024-1028.
39. Tanabe ., Kuwabara T., Warashina M., Tani K., Taira K., Asano S. Oncogene inactivation in a mouse model. Nature 2000; 406: 473-474.